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This daily COVID-19 Health Evidence Summary is to signpost DFID and other UK government 
departments to the latest relevant evidence and discourse on COVID-19 to inform and support 
their response. 
1. Health Evidence Summary 
COVID-19: learning from experience 
The Lancet | 28 March 2020 | Editorial 
https://doi.org/10.1016/S0140-6736(20)30686-3 
 
The next wave of infections will hit Africa and Latin America. The Africa CDC has reported 
cases in 41 countries. Fragile health systems will soon be overwhelmed if infection spreads 
widely, have only tens or hundreds of ventilators, and many health facilities do not even have 
oxygen. Many people living in poor, overcrowded, urbans areas do not have basic sanitation, 
could not self-isolate and have no paid sick leave or social security. The WHO COVID-19 
Solidarity Response Fund has raised more than US$70 million and some regional 
organisations have taken strong proactive action, sharing information and receiving donations 
of testing kits and medical supplies. Whilst many governments have responded quickly 
following WHO’s consistent, clear and evidence-based recommendations, not all have e.g. 
ignoring WHO’s recommendation on avoiding mass gatherings and must learn from Europe 
and the USA to not put off preparation. 
 
No time for dilemma: mass gatherings must be suspended 
The Lancet | 27 March 2020 | Correspondence  
https://www.thelancet.com/lancet/article/s0140-6736(20)30754-6 
 
This correspondence calls for all mass gatherings to be cancelled given the challenges of 
social distancing and continued disinfection of hard surfaces and to provide clear messaging 
to the public. The authors cite evidence supporting the cancellation of mass gathering where 
Saudi Arabia’s suspension of the Umrah pilgrimage was protective, whereas Iran’s decision 
to permit mass gatherings in Mashhad and Qom was detrimental.  
Key considerations: COVID-19 in informal urban settlements 
Wilkinson et al. | Social Science in Humanitarian Action | March 2020 | Brief 
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https://opendocs.ids.ac.uk/opendocs/bitstream/handle/20.500.12413/15185/SSHAP_COVID-
19_Key_Considerations_Informal_Settlements_final.pdf?sequence=3&isAllowed=y 
 
This brief offers seven summary considerations to develop locally appropriate and feasible 
approaches to protect the 1 billion people living in informal settlements from the worst impacts 
of COVID-19.  
 
Test Test Test for TB! Test for COVID-19! 
Stop TB Partnership | 27 March 2020 | News Article 
http://www.stoptb.org/news/stories/2020/ns20_012.html 
 
The Xpert Express SARS-CoV-2 cartridges are now available from the Stop TB Partnership’s 
Global Drug Facility at US$19.80 per cartridge from the manufacture Cepheid. Results are 
available in 45 minutes. The Xpert Express SARS-CoV-2 cartridge received Emergency Use 
Authorization (EUA) from the United States Food and Drug Administration (FDA) on 21 March 
2020. The cartridge can be used on any of the currently available GeneXpert systems 
(GeneXpert Systems running software version 4.7 or higher).  
 
LSTM begins the validation process for Mologic COVID-19 point-of-
need diagnostic test 
LSTM | 27 March 2020 | News article 
https://www.lstmed.ac.uk/news-events/news/lstm-begins-the-validation-process-for-the-
mologic-covid-19-point-of-need 
 
Independent assessment and validation of COVID-19 point of care diagnostic tests have been 
initiated this week with Mologic, LSTM and St Georges University London. Prototypes will be 
sent to world-leading labs in UK, Senegal, Spain, China, Malaysia and Brazil for priority 
validation. COVID-19 tests will be jointly manufactured in the UK at Mologic and in Senegal at 
Institut Pasteur de Dakar for the first time. The test will allow users to test for exposure to the 
virus at home, in the community, or in the clinic proving a result within 10 minutes without the 
need for special training, electricity or a laboratory. Mologic will sell the diagnostic test at cost 
to low-income settings. The accelerated development of the test has been made possible by 
funding from UK Aid, as part of the £46 million the UK government has announced so far for 
COVID-19 prevention and research. 
Stop TB Partnership tools for TB programmes and TB communities 
on TB and COVID-19  
Stop TB Partnership | 26 March 2020 | Tools 
http://www.stoptb.org/covid19.asp 
 
A portfolio of tools, content and resources to help support people with TB and TB programmes 
during the COVID-19 pandemic and beyond. (1) Alternative options such as virtual care, digital 
health and community-monitoring solutions. Rapid information note on how TB programmes 
can change to virtual mode. Re-imagining TB Care (developed in partnership with the McGill 
International TB Centre and the Arcady Group) provides initial mapping and database of 
available digital health, virtual care, and community-monitoring solutions across the TB care 
models and country profiles on how some countries have rolled-out some of these 
technologies. OneImpact solution (developed in partnership with community partners and 
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Dure Technologies) is a digital community-based monitoring alert system that is used by 
people and communities affected by TB to track and troubleshoot, in real-time, issues related 
to the availability and accessibility of quality TB services due to COVID-19. (2) TB and COVID-
19 webpage includes suggsetd actions, international and national guidelines, dashboards and 
data. 
 
The world’s largest refugee camp prepares for COVID-19 
Vince, G. | BMJ | 26 March 2020 | Feature 
https://doi.org/10.1136/bmj.m1205 
 
This report highlights preparations being made in Cox’s Bazar, Bangladesh, home to over 
855,000 Rohingya refugees from Myanmar. These include increasing hand washing facilities, 
communicating WHO public health information in the three languages spoken in the camp, 
discouraging gatherings where possible, working in partnership with government, including 
refugees in national decisions and measures and setting up isolation zones and units. 
Currently there are no refugee testing facilities, but there is currently scaling up of testing 
capacities across the country. 
 
COVID-19: Operational guidance for maintaining essential health 
services during an outbreak 
WHO | 25 March 2020 | Guidance 
https://www.who.int/publications-detail/covid-19-operational-guidance-for-maintaining-
essential-health-services-during-an-outbreak 
 
WHO guidance on targeted immediate actions that countries should consider at national, 
regional and local level to reorganise and maintain access to high-quality essential health 
services. This document expands on the Operational planning guidelines to support country 
preparedness and response. 
2. Tracking COVID-19 cases 
Global 
WHO COVID-19 daily situation reports 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports 
An interactive web-based dashboard to track COVID-19 in real time 
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd4029942
3467b48e9ecf6 
Live data tracker: sex-disaggregated COVID-19 data from the 25 most-affected 
countries 
http://globalhealth5050.org/covid19 
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Africa 
Africa Centres for Disease Control and Prevention (Africa CDC) 
http://www.africacdc.org/covid-19-and-resources 
Coronavirus in Africa Tracker: How many covid-19 cases & where? 
https://africanarguments.org/2020/03/23/coronavirus-in-africa-tracker-how-many-cases-and-
where-latest/ 
South African Government COVID-19 
https://www.gov.za/Coronavirus 
UK 
COVID-19: PHE track coronavirus cases in the UK 
https://www.gov.uk/government/publications/covid-19-track-coronavirus-cases 
UK case tracing infographic 
https://www.arcgis.com/apps/opsdashboard/index.html#/f94c3c90da5b4e9f9a0b19484dd4b
b14 
3. Online course 
COVID-19: Tackling the Novel Coronavirus 
LSHTM | FutureLearn course | Starts 23 March 2020 | 3 weeks | 4 hours weekly study | Free 
https://www.futurelearn.com/courses/covid19-novel-coronavirus 
A reminder that this course is currently running. On this course you will learn what is known 
about the outbreak of COVID-19 (week 1); what the practical implications for responding to 
COVID-19 are (week 2); and what we need to find out about COVID-19 (week 3). 
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4. Resource Hubs 
Special Collection: Coronavirus (COVID-19): evidence relevant to critical care 
https://www.cochrane.org/news/special-collection-coronavirus-covid-19-evidence-relevant-
critical-care 
NICE UK: Rapid guidelines and evidence reviews  
https://www.nice.org.uk/covid-19 
Imperial College London MRC Centre for Global Infectious Disease Analysis COVID-19 
reports 
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/ 
Global research on COVID-19 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/global-research-on-
novel-coronavirus-2019-ncov 
WHO R&D Blueprint 
https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus/en/ 
WHO: Coronavirus disease (COVID-19) outbreak resources 
https://www.who.int/emergencies/diseases/novel-coronavirus-2019 
Latest information and advice from the UK Government 
https://www.gov.uk/guidance/coronavirus-covid-19-information-for-the-public 
CDC COVID-19 Resources 
https://www.cdc.gov/coronavirus/2019-ncov/index.html 
The Lancet COVID-19 Resource Centre 
https://www.thelancet.com/coronavirus 
Elsevier’s Novel Coronavirus Information Center 
https://www.elsevier.com/connect/coronavirus-information-center 
6 
Cell Press Coronavirus Resource Hub 
https://www.cell.com/2019-nCOV 
Cochrane Special Collections - COVID-19: infection control and prevention measures 
https://www.cochranelibrary.com/collections/doi/SC000040/full 
The BMJ Coronavirus (covid-19): Latest news and resources 
https://www.bmj.com/coronavirus?int_source=wisepops&int_medium=wisepops&int_campai
gn=DAA_CoronaVirus_Jan24 
Johns Hopkins Coronavirus Resource Centre 
https://coronavirus.jhu.edu 
Global Partnership for Sustainable Development – COVID-19 resources 
http://www.data4sdgs.org/resources/covid-19-resources 
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